Maxnerva Technology Services Limited (MAXNERVA TECH) filed its Monthly Return for Equity Issuer covering the period to 30 September 2026, confirming a stable capital structure with minor adjustments to its share-based incentive plans.

Authorised and Issued Capital • Authorised share capital stayed unchanged at 1.00 billion ordinary shares with a par value of HKD 0.10 each, representing HKD 100.00 million in authorised capital. • Issued share capital remained at 706.17 million ordinary shares; no new shares were issued and no treasury shares were held or cancelled during the month. • The company affirmed compliance with the Hong Kong Exchange’s minimum public-float requirement of 25%.

Share Option Movements • Total outstanding share options declined to 6.62 million, down by 0.20 million options due to cancellations. – 2017 Grant: 0.10 million options cancelled; 1.25 million remain outstanding. – 2018 Grant: 0.10 million options cancelled; 2.72 million remain outstanding. – 2022 Grant: unchanged at 2.65 million outstanding. • No options were exercised; consequently, no shares were issued and no funds were raised.

Other Equity Instruments • The company reported no outstanding warrants, convertible securities, or other share-issuance arrangements.

Resulting Equity Profile • Post-month-end, MAXNERVA TECH retains 706.17 million issued shares and HKD 100.00 million in authorised capital. • The current outstanding option pool represents approximately 0.94% of the company’s issued share base.

The filing underscores MAXNERVA TECH’s steady share capital position in September 2026, with shareholder dilution held in check and statutory public-float levels comfortably maintained.